2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theGastroparesis Drugs Market?

The growth of the gastroparesis drugs market is anticipated to be fueled by the escalating incidence of diabetes. Recognized as a chronic health concern characterized by elevated blood sugar levels, diabetes results from insufficient insulin production or the body’s poor response to insulin. Factors like inactive lifestyles, unhealthy eating habits, genetic factors, urban growth, and aging populations contribute to the rising trend of diabetes, augmented by restricted healthcare access and a global surge in obesity. Drugs for gastroparesis, a common complication in diabetic patients characterized by symptoms like nausea, vomiting, and tardy gastric emptying, are commonly prescribed. These drugs aim to enhance gastric function and improve life quality for those suffering from diabetes-related gastroparesis. As per the Office for Health Improvement & Disparities, a UK Government department, records from March 2022 to March 2023 show a marked rise of 22% and 21% in the percentage of individuals with type 1 and type 2 diabetes respectively, receiving all eight recommended care processes. Moreover, those achieving target HbA1c levels rose to the highest ever reported at 37.9%, according to the National Diabetes Audit (NDA). Consequently, the escalating incidence of diabetes is propelling the gastroparesis drugs market growth.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15812&type=smp

#What is the Anticipated CAGR of theGastroparesis Drugs Market, and What Factors Will Drive It?

The market for gastroparesis drugs has seen robust growth in the past few years. The market size is predicted to expand from $5.39 billion in 2024 to $5.73 billion in 2025, witnessing a compound annual growth rate (CAGR) of 6.3%. This substantial growth during the historic period is due to factors such as the side effects of current treatment methods, research on gastrointestinal motility, clinical demand, patient advocacy, and regulatory backing.

The market size of drugs for gastroparesis is anticipated to witness robust growth in the upcoming years. By 2029, it’s projected to reach $7.2 billion, with a compound annual growth rate (CAGR) of 5.9%. The growth within this forecast period can be credited to factors like the rising cases of diabetes, an aging demographic, escalating awareness and diagnosis rates, an increase in healthcare spending and both government and private sector funding. Key trends expected in this forecast timeframe include developments in gastroenterology, enhanced diagnostic methodologies, technological breakthroughs, allocation of funds for research and combined research initiatives.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15812

What Key Market Trends and Innovations Are Shaping the Future of theGastroparesis Drugs Industry?

Leading players in the gastroparesis drugs industry are concentrating on the launch of groundbreaking medicines like Gimoti (metoclopramide) nasal spray to secure a competitive advantage. This drug is utilized to manage gastroparesis symptoms in adults by accelerating gastric emptying through enhanced gastrointestinal mobility. Unlike other treatments, it doesn’t pass through the digestive tract and is instead directly assimilated into the bloodstream via the nasal lining. As an example, in April 2022, Evoke Pharma Inc., a pharmaceutical company based in the United States, proclaimed the U.S. Food and Drug Administration (FDA) gave exclusivity for their new drug, GIMOTI (metoclopramide) nasal spray. With the protection afforded by the Hatch-Waxman Act, this exclusivity will shield the product from generic competitors for three years from its original approval, giving Evoke sole rights to its marketing.

Which Companies Are Leading the Charge in Expanding theGastroparesis Drugs Market Growth?

Major companies operating in the gastroparesis drugs market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA., AstraZeneca plc, Abbott Laboratories, GSK plc, Takeda Pharmaceutical Inc., Teva Pharmaceutical Inc., Otsuka Pharmaceutical Co. Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Evoke Pharma Inc., Cadila Pharmaceuticals, Cipla Ltd., Neurogastrx Inc., Ipca Laboratories Ltd., ANI Pharmaceuticals Inc., Salix Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Theravance Biopharma Inc., Rhythm Pharmaceuticals Inc., Processa Pharmaceuticals Inc., Aclipse Therapeutics LLC, ETX Pharma Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/gastroparesis-drugs-global-market-report

How is the Global Gastroparesis Drugs Market Segemented?

The gastroparesis drugs market covered in this report is segmented –

1) By Drug Type: Over-the-counter (OTC) Drugs, Prescription Drugs

2) By Drug Class: Prokinetic Agents, Antiemetic Drugs, Proton Pump Inhibitors, Other Drug Classes

3) By Disease Type: Diabetic Gastroparesis, Post-Surgical Gastroparesis, Idiopathic Gastroparesis, Other Disease Types

4) By Route Of Administration: Oral, Injectables, Other Routes Of Administration

5) By Distribution Channel: Hospitals, Pharmacies, Clinics, E-commerce

Subsegments:

1) Over-the-counter (OTC) Drugs: Antacids, Anti-Nausea Medications, Antiemetics, Digestive Enzyme Supplements

2) Prescription Drugs: Prokinetic Agents, Antiemetic Drugs, Antibiotics, Antidepressants

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15812&type=smp

Which Geographics are Influencing the Growth of the Gastroparesis Drugs Market?

North America was the largest region in the gastroparesis drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroparesis drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Gastroparesis Drugs Market 2025, By The Business Research Company:

Fertility Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report

Gastrointestinal Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

Gastrointestinal Bleeding Treatment Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: